Aviva PLC Karuna Therapeutics, Inc. Transaction History

Aviva PLC

  • $36.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
SELL
$107.45 - $135.95 $1.14 Million - $1.44 Million
-10,579 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$95.46 - $133.08 $499,542 - $696,407
-5,233 Reduced 33.1%
10,579 $1.27 Million
Q4 2020

Feb 10, 2021
SELL
$75.23 - $109.23 $964,373 - $1.4 Million
-12,819 Reduced 44.77%
15,812 $1.61 Million
Q3 2020

Nov 12, 2020
BUY
$71.31 - $109.74 $2.04 Million - $3.14 Million
28,631 New
28,631 $2.21 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email